5-Hydroxytryptamine-induced excitatory postsynaptic currents in neocortical layer V pyramidal cells: Suppression by μ-opiate receptor activation

Neuroscience

Volumn 86, Issue 2, 1998, Pages 485-497

  Marek, G J ^a   Aghajanian, G K ^a  

^a Yale University School of Medicine   (United States)

Author keywords

receptors; 5 HT; 5 HT(2A) receptor; Endomorphin 1; Medial prefrontal cortex; Opiates

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; ENDORPHIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; EXCITATORY AMINO ACID RECEPTOR; METENKEPHALIN; MU OPIATE RECEPTOR; NALTRINDOLE; NORBINALTORPHIMINE; OPIATE AGONIST; OPIATE RECEPTOR; RECEPTOR SUBTYPE; SEROTONIN; SEROTONIN 2A RECEPTOR;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; MALE; NEOCORTEX; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; VOLTAGE CLAMP;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALIN, METHIONINE; ENKEPHALINS; EVOKED POTENTIALS; EXCITATORY POSTSYNAPTIC POTENTIALS; MALE; MODELS, NEUROLOGICAL; NEOCORTEX; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, OPIOID, MU; RECEPTORS, SEROTONIN; SEROTONIN; SOMATOSTATIN; SYNAPSES;

EID: 0032100675     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00043-8     Document Type: Article

References (49)

1. Aghajanian G. K., Marek G. J. Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology. 36:1997;589-599.
2. Aghajanian G. K., Rasmussen K. Intracellular studies in the facial nucleus illustrating a simple new method for obtaining viable motoneurons in adult rat brain slices. Synapse. 3:1989;331-338.
3. Altar C. A., Wasley A. M., Neale R. F., Stone G. A. Typical and atypical antipsychotic occupancy of D2 and S2 receptors: an autoradiographic analysis in rat brain. Brain Res. Bull. 16:1986;517-525.
4. Arunlakshana O., Schild H. O. Some quantitative uses of drug antagonists. Br. J. Pharmac. 14:1959;48-58.
5. Attwell P. J. E., Kaura S., Sigala G., Bradford H. F., Croucher M. J., Jane D. E., Watkins J. C. Blockade of both epileptogenesis and glutamate release by (1S,3S)-ACPD, a presynaptic glutamate receptor agonist. Brain Res. 698:1995;155-162.
6. Bacon S. J., Headlam A. J. N., Gabbott P. L. A., Smith A. D. Amygdala input to medial prefrontal cortex (mPFC) in the rat: a light and electron microscope study. Brain Res. 720:1996;211-219.
7. 2 receptors and serotonergic axons in rat neocortex. Brain Res. 453:1988;315-328.
8. Bodkin J. A., Zornberg G. L., Lukas S. E., Cole J. O. Buprenorphine treatment of refractory depression. J. clin. Psychopharmac. 15:1995;49-57.
9. Bradford H. F., Crowder J. M., White E. J. Inhibitory actions of opioid compounds on calcium fluxes and neurotransmitter release from mammalian cerebral cortical slices. Br. J. Pharmac. 88:1986;87-93.
10. + channel. J. biol. Chem. 269:1994;7839-7842.
11. Comfort A. Morphine as an antipsychotic? Clin. Tox. 11:1977;383-386.
12. Connors B. W., Gutnick M. J. Intrinsic firing patterns of diverse neocortical neurons. Trends Neurosci. 13:1990;99-104.
13. Corne S. J., Pickering R. W., Warner B. T. A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine. Br. J. Pharmac. 20:1963;106-120.
14. Delphs J. M., Kong H., Mestek A., Chen Y., Yu L., Reisine T., Chesselet M.-F. Expression of mu opioid receptor mRNA in rat brain: an in situ hybridization study at the single cell level. J. comp. Neurol. 345:1994;46-68.
15. Di Chiara G., North R. A. Neurobiology of opiate abuse. Trends pharmac. Sci. 13:1992;185-193.
16. Domino E. F. Opioid-hallucinogenic interactions. Pharmac. Biochem. Behav. 24:1986;401-405.
17. 2 receptor-mediated excitation of interneurons in pirform cortex: antagonism by atypical antipsychotic drugs. Neuroscience. 58:1994;515-525.
18. Gold M. S., Donabedian R. K., Dillard M., Slobetz F. W., Riordan C. E., Kleber H. D. Antipsychotic effect of opiate agonists. Lancet. 2:1977;398-399.
19. Granhoff M. I., Lee L., Jackson A., Patel K., Martinez Y., Ashby C. R., Wang R. Y. The interaction of 5-HT1A and 5-HT2 receptors in the medial prefrontal cortex: behavioral studies. Soc. Neurosci. Abstr. 18:1992;1380.
20. Jakab R. L., Goldman-Rakic P. S. 5-HT2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogens in pyramidal cell apical dendrites. Proc. natn. Acad. Sci. U.S.A. 00:1998;000-000.
21. Krettek J. E., Price J. L. Projections from the amygdaloid complex to the cerebral cortex and thalamus in the rat and cat. J. comp. Neurol. 172:1977;687-722.
22. Lewis M. E., Pert A., Pert C. B., Herkenham M. Opiate receptor localization in rat cerebral cortex. J. comp. Neurol. 216:1983;339-358.
23. Mansour A., Fox C. A., Burke S., Meng F., Thompson R. C., Akil H., Watson S. J. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J. comp. Neurol. 350:1994;412-438.
24. Mansour A., Fox C. A., Thompson R. A., Akil H., Watson S. J. μ-Opioid receptor mRNA expression in the rat CNS: comparison to μ-receptor binding. Brain Res. 643:1994;245-265.
25. 2A receptor antagonist. Eur. J. Pharmac. 259:1994;137-141.
26. 2A receptors on neurons in the rat piriform cortex. J. Pharmac. exp. Ther. 278:1996;1373-1382.
27. Marek G. J., Aghajanian G. K. The electrophysiology of prefrontal 5-HT systems: therapeutic implications for mood and psychosis. Biol. Psychiat. 00:1998;000-000.
28. Marek G. J., McDougle C. J., Price L. H., Seiden L. S. A comparison of trazodone and fluoxetine: implications for a serotonergic mechanism of antidepressant action. Psychopharmacology. 109:1992;2-11.
29. McCormick D. A., Connors B. W., Lighthall J. W., Prince D. A. Comparative electrophysiology of pyramidal and sparsely spiny neurons of the neocortex. J. Neurophysiol. 54:1985;782-806.
30. McLean S., Rothman R. B., Herkenham M. Autoradiographic localization of μ- and δ-opiate receptors in the forebrain of the rat. Brain Res. 378:1986;49-60.
31. i values. J. Pharmac. exp. Ther. 251:1989;238-246.
32. + evoked glutamate release from rat cerebrocortical slices. Neurosci. Lett. 218:1996;79-82.
33. O'Brien C. P., Woody G. E., McLellan A. T. Psychiatric disorders in opioid-dependent patients. J. clin. Psychiat. 45:1984;9-13.
34. Pazos A., Palacios J. M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res. 346:1985;205-230.
35. Pineda J., Kogan J. H., Aghajanian G. K. Nitric oxide and carbon monoxide activate locus coeruleus neurons through a cGMP-dependent protein kinase: involvement of a nonselective cationic channel. J. Neurosci. 16:1996;1389-1399.
36. 2 binding affinity. Neuropsychopharmacology. 1:1988;101-107.
37. Sahin M., Bowen W. D., Donoghue J. P. Location of nicotinic and muscarinic cholinergic and μ-opiate receptors in rat cerebral neocortex: evidence from thalamic and cortical lesions. Brain Res. 579:1992;135-147.
38. Sanchez-Prieto J., Budd D. C., Herrero I., Vazquez E., Nicholls D. G. Presynaptic receptors and the control of glutamate exocytosis. Trends Neurosci. 19:1996;235-239.
39. 2-activated interneuron. Brain Res. 506:1990;62-69.
40. Takemori A. E., Ho B. Y., Naeseth J. S., Portoghese P. S. Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J. Pharmac. exp. Ther. 246:1988;255-258.
41. Tanaka E., North R. A. Opioid actions on rat anterior cingulate cortex neurons in vitro. J. Neurosci. 14:1994;1106-1113.
42. Tempel A., Zukin R. S. Neuroanatomical patterns of the μ, δ, and κ opioid receptors of rat brain as determined by quantitative in vitro autoradiography. Proc. natn. Acad. Sci. U.S.A. 84:1987;4308-4312.
43. 2 receptor as a site of action for LSD and phenethylamine hallucinogens. Psychopharmacology. 94:1988;213-216.
44. Vetulani J., Bednarczyk B., Reichenberg K., Rokosz A. Head twitches induced by LSD and quipazine: similarities and differences. Neuropharmacology. 19:1980;155-158.
45. Vogt B. A., Wiley R. G., Jensen E. L. Localization of mu and delta opioid receptors to anterior cingulate afferents and projection neurons and input/output model of mu regulation. Expl Neurol. 135:1995;83-92.
46. Willins D. L., Meltzer H. Y. Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats. J. Pharmac. exp. Ther. 282:1997;000-000.
47. 2 receptor subtype mRNAs in rat brain. J. comp. Neurol. 351:1995;357-373.
48. Zadina J. E., Hackler L., Ge L.-J., Kastin A. J. A potent and selective endogenous agonist for the μ-opiate receptor. Nature. 386:1997;499-502.
49. Zilles (1985) Details?